Kevin Dawravoo works in the field of Oncology. He went to Creighton University School of Medicine. Creighton University School of Medicine is ranked 79 in research and 78 in primary care medicine He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Kevin Dawravoo has written publications. He has 1 publication published with PubMed. The lastest paper is: 'Randomized phase III trial of pegfilgrastim versus filgrastim after autologus peripheral blood stem cell transplantation.' Doctor Kevin Dawravoo, MD accepts Medicare payments and is registered with Medicare.gov.
NPI NUMBER | 1912163114 | |
NPPES Provider LastName | DAWRAVOO | |
NPPES Provider FirstName | KEVIN | |
NPPES Provider ZIPCode | 605553269 | |
NPPES Provider State | IL | |
Specialty Description | Hematology/Oncology | |
Total Claim Count | 164.0 | |
Distinct Opioid Count | 0.0 | |
Opioid Claim Count | 0.0 | |
Percent Opioid Claims | 0.0 |
National Provider Identifier [NPI] | 1912163114 |
Last Name Of The Provider | DAWRAVOO |
First Name Of The Provider | KEVIN |
View All |
![]() |
Dr. Robert M. Eisner, DO
![]() |
![]() |
Dr. Laura E. Horvath, MD |
![]() |
Dr. Michael Kahn, MD
![]() |